Cytosorbents Corporation (CTSO)
NASDAQ: CTSO
· Real-Time Price · USD
1.15
0.01 (0.88%)
At close: Aug 15, 2025, 3:59 PM
1.14
-0.42%
After-hours: Aug 15, 2025, 06:51 PM EDT
Cytosorbents Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 33.48M | 32.7M | 32.97M | 33.79M | 32.93M | 32.16M | 31.08M | 31.38M | 30.09M | 29.35M | 29.36M | 31.42M | 33.85M | 37.89M | 40.11M | 41.94M | 43.28M | 41.44M |
Cost of Revenue | 9.68M | 10.27M | 10.96M | 14.07M | 13.17M | 13.18M | 13.96M | 14.23M | 15.52M | 15.67M | 13.96M | 13.45M | 11.41M | 10.57M | 11.05M | 10.45M | 10.88M | 11.42M |
Gross Profit | 24.3M | 23.99M | 24.65M | 22.88M | 22.93M | 21.1M | 18.14M | 17.14M | 14.56M | 13.67M | 15.4M | 17.97M | 22.44M | 27.32M | 29.52M | 31.94M | 32.86M | 30.48M |
Operating Income | -15.94M | -15.75M | -16.52M | -22.11M | -25.07M | -28.21M | -31.44M | -28.16M | -29.82M | -31.62M | -31.52M | -34.73M | -31.12M | -27.68M | -22.75M | -15.82M | -12.37M | -10.74M |
Interest Income | n/a | n/a | n/a | n/a | n/a | 8.82K | 8.82K | 62.57K | 109.41K | 124.57K | 132.59K | 91.14K | 57.06K | 46.16K | 38.13K | 25.84K | 13.07K | n/a |
Pretax Income | -11.44M | -17.53M | -22.14M | -19.21M | -26.07M | -28.08M | -29.32M | -24.53M | -27.54M | -32.27M | -33.91M | -42.09M | -36.29M | -30.09M | -25.3M | -17.06M | -11.49M | -9.68M |
Net Income | -9.75M | -15.84M | -20.72M | -18.67M | -25.53M | -27.54M | -28.51M | -23.44M | -26.4M | -31.13M | -32.77M | -41.31M | -35.56M | -29.36M | -24.56M | -15.93M | -10.36M | -8.55M |
Selling & General & Admin | 35.19M | 34.43M | 35.28M | 34.69M | 36.13M | 36.64M | 36.49M | 35.96M | 36.1M | 36.31M | 37.14M | 39.51M | 38.61M | 40.03M | 38.48M | 36.77M | 36.2M | 33.09M |
Research & Development | 6.07M | 6.33M | 6.92M | 9.71M | 11.61M | 13.76M | 15.73M | 15.03M | 14.57M | 15.09M | 15.12M | 17.85M | 18.82M | 18.34M | 16.38M | 12.93M | 10.42M | 9.13M |
Other Expenses | 1.58M | 1.58M | 1.58M | 1.3M | 246.77K | -1.1M | -2.64M | -5.69M | -6.28M | -6.1M | -5.33M | -4.67M | -3.88M | -3.37M | -3.06M | -2.4M | -1.84M | -1.46M |
Operating Expenses | 42.85M | 42.34M | 43.78M | 45.71M | 47.99M | 49.47M | 49.74M | 45.47M | 44.55M | 45.3M | 46.93M | 52.7M | 53.75M | 55.19M | 52M | 47.5M | 44.78M | 40.76M |
Interest Expense | 2.43M | 2M | 1.4M | 827.13K | 272.65K | 101.37K | 157.89K | 159.41K | 172.58K | 163.76K | 100.59K | 46.84K | n/a | n/a | 10.12K | 371.22K | 632.22K | 906.04K |
Selling & Marketing Expenses | 14.82M | 14.82M | 14.86M | 5.72M | -1.28M | -1.28M | -1.31M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 52.05M | 52.13M | 53.16M | 56.66M | 58.75M | 60.07M | 62.23M | 59.54M | 59.91M | 60.97M | 60.88M | 66.14M | 64.97M | 65.57M | 62.85M | 57.76M | 55.66M | 52.19M |
Income Tax Expense | -1.69M | -1.69M | -1.69M | -814.01K | -814.01K | -814K | -814K | -1.09M | -1.14M | -1.14M | -1.15M | -790.87K | -756.79K | -769.87K | -761.84K | -1.15M | -1.14M | -1.13M |
Shares Outstanding (Basic) | 62.61M | 60.73M | 54.72M | 54.72M | 54.31M | 54.26M | 44.66M | 44.37M | 44.02M | 43.68M | 43.48M | 43.58M | 43.56M | 42.7M | 43.36M | 42.71M | 42.52M | 41.68M |
Shares Outstanding (Diluted) | 67.17M | 60.73M | 54.72M | 54.45M | 54.31M | 54.26M | 44.66M | 44.37M | 44.02M | 43.68M | 43.48M | 43.61M | 43.56M | 43.49M | 43.48M | 43.4M | 43.32M | 43.24M |
EPS (Basic) | -0.18 | -0.28 | -0.37 | -0.36 | -0.53 | -0.59 | -0.65 | -0.54 | -0.61 | -0.72 | -0.76 | -0.96 | -0.83 | -0.69 | -0.58 | -0.38 | -0.25 | -0.22 |
EPS (Diluted) | -0.18 | -0.28 | -0.37 | -0.36 | -0.53 | -0.59 | -0.65 | -0.54 | -0.61 | -0.72 | -0.76 | -0.95 | -0.82 | -0.68 | -0.57 | -0.38 | -0.25 | -0.22 |
EBITDA | -16.49M | -15.85M | -21.02M | -16.03M | -23.41M | -26.54M | -28.48M | -28.45M | -28.5M | -30.46M | -30.39M | -33.32M | -29.75M | -26.48M | -22.97M | -15.25M | -10.5M | -8.14M |
EBIT | -11.58M | -17.56M | -22.77M | -18.14M | -25.56M | -28.68M | -30.49M | -29.95M | -29.8M | -31.5M | -31.39M | -34.26M | -30.65M | -27.34M | -23.71M | -15.93M | -11.11M | -8.77M |
Depreciation & Amortization | 1.71M | 1.71M | 1.75M | 2.11M | 2.15M | 2.16M | 2.03M | 1.51M | 1.33M | 1.16M | 1.13M | 1.07M | 1.03M | 857.34K | 731.58K | 682.97K | 601K | 635.74K |